Probiotic and Postbiotic Sales Surge 22 in 2024, as Consumers Prioritize Gut-Brain Health

Sales of probiotic and postbiotic products in key markets (U.S., China, EU) surged 22% in 2024, reaching $18.7 billion, according to data from Euromonitor International. The growth is fueled by mounting scientific evidence linking gut health to mental well-being, immune function, and metabolic health, with consumers increasingly seeking products backed by clinical trials and strain-specific certifications.

Leading brands are responding with innovative formulations, such as synbiotic blends (combining probiotics with prebiotics) and postbiotic supplements that deliver targeted benefits without live bacteria. "The gut-brain axis is no longer a niche topic—it’s a mainstream consumer concern," said Sarah Lee, a product development director at a global nutrition company. "We’re seeing strong demand for products that address stress, anxiety, and digestive issues through evidence-based gut health solutions."